Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees

  1. Jens Bukh*,,
  2. Thomas Pietschmann,§,
  3. Volker Lohmann,§,
  4. Nicole Krieger,§,
  5. Kristina Faulk*,
  6. Ronald E. Engle*,
  7. Sugantha Govindarajan,
  8. Max Shapiro,
  9. Marisa St. Claire, and
  10. Ralf Bartenschlager,§
  1. *Hepatitis Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; Institute for Virology, Johannes Gutenberg University, Mainz 55131, Germany;§ Department of Molecular Virology, Institute of Hygiene, University of Heidelberg, Heidelberg 69120, Germany; Liver Research Laboratory, Rancho Los Amigos Medical Center, Downey, CA 90242; and Bioqual Incorporated, Rockville, MD 20850
  1. Communicated by Robert H. Purcell, National Institutes of Health, Bethesda, MD (received for review August 6, 2002)

Abstract

The development of a subgenomic replicon derived from the hepatitis C virus (HCV) strain Con1 enabled the study of viral RNA replication in Huh-7 cells. The level of replication of replicons, as well as full-length Con1 genomes, increased significantly by a combination of two adaptive mutations in NS3 (E1202G and T1280I) and a single mutation in NS5A (S2197P). However, these cell culture-adaptive mutations influenced in vivo infectivity. After intrahepatic transfection of chimpanzees, the wild-type Con1 genome was infectious and produced viral titers similar to those produced by other infectious HCV clones. Repeated independent transfections with RNA transcripts of a Con1 genome containing the three adaptive mutations failed to achieve active HCV infection. Furthermore, although a chimpanzee transfected with RNA transcripts of a Con1 genome with only the NS5A mutation became infected, this mutation was detected only in virus genomes recovered from serum at day 4; viruses recovered at day 7 had a reversion back to the original Con1 sequence. Our study demonstrates that mutations that are adaptive for replication of HCV in cell culture may be highly attenuating in vivo.

Footnotes

  • To whom correspondence should be addressed. E-mail: jbukh{at}niaid.nih.gov.

  • Abbreviations:
    1. HCV, hepatitis C virus

    2. HAV, hepatitis A virus

    3. p.i., postinoculation

    4. E, envelope

    5. NS, nonstructural

    6. ALT, alanine aminotransferase

« Previous | Next Article »Table of Contents